{
    "eid": "2-s2.0-84956731251",
    "title": "Metformin does not improve survival of cholangiocarcinoma patients with diabetes",
    "cover-date": "2016-02-01",
    "subject-areas": [
        {
            "$": "Hepatology",
            "@code": "2721"
        }
    ],
    "keywords": [],
    "authors": [
        "Zhen Yang"
    ],
    "citedby-count": 17,
    "ref-count": 3,
    "ref-list": [
        "Metformin and cancer risk in diabetic patients: A systematic review and meta-analysis",
        "Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: A systematic review and meta-analysis",
        "Risk factors for intrahepatic cholangiocarcinoma: Association between metformin use and reduced cancer risk"
    ],
    "affiliation": [
        {
            "affiliation-city": "Rochester",
            "affilname": "Mayo Clinic",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Jinan",
            "affilname": "Shandong Provincial Hospital",
            "affiliation-country": "China"
        }
    ],
    "funding": []
}